ArticleCancer research2021
Open access · bronzeAbstract read
In one paragraph
Article in Cancer research, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 107 papers.
0numbers the graph read from it
0cells of the map it votes in
107citing papers in PubMed
11.0field-weighted citation impact, top 1% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
107 citing papers in PubMed, 146 citations in OpenAlex.
- DMAMCL induces ferroptosis in neuroblastoma by targeting HMOX1 in MYCN-amplified subtypes whereas targeting STEAP3 in MYCN-nonamplified subtypes.Redox report : communications in free radical research · 2026Article
- Targeted extracellular degradation of LRP8 promotes ferroptosis in cancer cells.Proceedings of the National Academy of Sciences of the United States of America · 2026Article
- The Emerging Role of Ferroptosis in Pediatric Cancer Biology and Therapy.International journal of molecular sciences · 2026Review
- Unveiling the molecular landscape: Long non-coding RNAs in neuroblastoma (Review).Oncology reports · 2026Review
- MYCN Amplification Drives Ferroptosis Susceptibility via Cysteine Metabolism in Retinoblastoma.Investigative ophthalmology & visual science · 2026Article
- Reprogramming lipid metabolism in pediatric cancers.Oncogenesis · 2026Review
- Spatial multi-omics characterization of neuroblastoma reveals ferroptosis-associated metabolic features in high-risk tumors.Genome medicine · 2026Article
- Repurposing dronedarone induces ferroptosis through GPX4 inactivation and degradation in pancreatic cancer.Journal of experimental & clinical cancer research : CR · 2026Article
- NAA20-mediated ACF1 lactylation drives neuroblastoma progression through enhancing GCLM-dependent glutathione synthesis.Cell biology and toxicology · 2026Article
- Deciphering the MYCN-driven metabolic microenvironment of neuroblastoma.Trends in molecular medicine · 2026Review
- Oncogenic role of the SLC7A13-SLC3A1 cystine transporter in human luminal breast cancer and its cryo-EM structure.Protein & cell · 2026Article
- Research progress on the regulation of ferroptosis in NPC (Review).Oncology reports · 2026Review
- Exploring Lipid Metabolic Reprogramming: Mechanistic Insights and Implications for Tumor Radiotherapy.International journal of biological sciences · 2026Review
- Antidepressant-like effects of Rg1 by mycn: promotion of neurogenesis in the hippocampus.Frontiers in pharmacology · 2026Article
- Iron-Driven Ferroptosis in Diabetic Kidney Disease: From Molecular Mechanisms to Targeted Therapeutic Translation.Diabetes, metabolic syndrome and obesity : targets and therapy · 2026Review
- Long non-coding RNA RP11-196G11.6 inhibits neuroblastoma progression by regulating the miR-376a-3p/RYBP signaling axis.Oncology letters · 2026Article
- Decoding ferroptosis for cancer therapy.Nature reviews. Cancer · 2025Review
- Exploring Natural Products to Target Ferroptosis in Urologic Malignancies: Advancements from Molecular Mechanisms to Therapeutic Strategies.Chinese journal of integrative medicine · 2025Review
- 6-Aminonicotinamide enhances the efficacy of 5-aminolevulinic acid-mediated photodynamic therapy for neuroblastoma.BMC cancer · 2025Article
- Targeting SUMOylation promotes cBAF complex stabilization and disruption of the SS18::SSX transcriptome in synovial sarcoma.Nature communications · 2025Article
47 more citing papers are in PubMed but not listed here.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
19 authors at 4 institutions in 1 country.
Konstantinos V Floros *School of Dentistry, VCU Philips Institute and Massey Cancer Center, Richmond, Virginia.ORCID 0000-0003-4916-2257
JinYang Cai *School of Dentistry, VCU Philips Institute and Massey Cancer Center, Richmond, Virginia.
Sheeba Jacob *School of Dentistry, VCU Philips Institute and Massey Cancer Center, Richmond, Virginia.
Richard KurupiSchool of Dentistry, VCU Philips Institute and Massey Cancer Center, Richmond, Virginia.
Carter K FairchildSchool of Dentistry, VCU Philips Institute and Massey Cancer Center, Richmond, Virginia.
Mayuri ShendeDepartment of Pathology, Virginia Commonwealth University and Massey Cancer Center, Richmond, Virginia.
Colin M CoonSchool of Dentistry, VCU Philips Institute and Massey Cancer Center, Richmond, Virginia.
Krista M PowellSchool of Dentistry, VCU Philips Institute and Massey Cancer Center, Richmond, Virginia.
Benjamin R BelvinSchool of Dentistry, VCU Philips Institute and Massey Cancer Center, Richmond, Virginia.
Bin HuDepartment of Pathology, Virginia Commonwealth University and Massey Cancer Center, Richmond, Virginia.
Madhavi PuchalapalliDepartment of Pathology, Virginia Commonwealth University and Massey Cancer Center, Richmond, Virginia.
Sivapriya RamamoorthyDiscovery and Translational Sciences, Metabolon Inc., Research Triangle Park, North Carolina.
Kimberly SwiftDiscovery and Translational Sciences, Metabolon Inc., Research Triangle Park, North Carolina.
Janina P LewisSchool of Dentistry, VCU Philips Institute and Massey Cancer Center, Richmond, Virginia.
Mikhail G DozmorovDepartment of Biostatistics, Virginia Commonwealth University, Richmond, Virginia.ORCID 0000-0002-0086-8358
John GlodNational Cancer Institute Pediatric Oncology Branch, Bethesda, Maryland.
Jennifer E KoblinskiDepartment of Pathology, Virginia Commonwealth University and Massey Cancer Center, Richmond, Virginia.ORCID 0000-0002-7156-2030
Sosipatros A BoikosDivision of Hematology, Oncology and Palliative Care, Virginia Commonwealth University and Massey Cancer Center, Richmond, Virginia.
Anthony C FaberSchool of Dentistry, VCU Philips Institute and Massey Cancer Center, Richmond, Virginia. acfaber@vcu.edu.
Virginia Cancer Institute · USVirginia Commonwealth University · USResearch Triangle Park Foundation · USNational Cancer Institute · US
Funding
Pediatric Oncology Branch Clinical Care and EducationZIEBC011516 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI GLOD, JOHN · 2013 to 2025
$69.1MVirus Vector Shared ResourceP30CA016059 · NCI · VIRGINIA COMMONWEALTH UNIVERSITY · PI Keri R Maher · 1985 to 2026
$51.0MABT-199 based therapies to treat neuroblastomaR01CA215610 · NCI · VIRGINIA COMMONWEALTH UNIVERSITY · PI Anthony Charles Faber · 2017 to 2026
$2.9MIntramural NIH HHS ZIE BC011516NCI NIH HHS P30 CA016059NCI NIH HHS R01 CA215610
Abstract
PubMed holds no abstract for this paper.
Indexed as
AnimalsAntioxidantsAuranofinCell Line, TumorCell ProliferationCell SurvivalChildEnzyme InhibitorsFerroptosisGene AmplificationGene Expression Regulation, EnzymologicGlutathioneHumansIronMaleMice(4-(bis(4-chlorophenyl)methyl)-1-piperazinyl)(5-methyl-4-nitro-1,2-oxazol-3-yl)methanoneAntioxidantsAuranofinEnzyme InhibitorsGlutathioneIronMYCN protein, humanN-Myc Proto-Oncogene ProteinOxazolesPhospholipid Hydroperoxide Glutathione PeroxidasePiperazinesSulfasalazine
Identifiers
What OpenQuestion holds
Textmetadata
LicenceTDM
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.